Nov 29, 2024, 20:13
Joshua Brody: Bispecific antibody immunotherapy for lymphoma
Joshua Brody, Director of Lymphoma Immunotherapy Program at The Icahn School of Medicine at Mount Sinai, shared on LinkedIn:
“Honored to be chairing this ASH24 session on bispecific antibody immunotherapy for lymphoma on behalf of Krish Patel, Sarah Cannon Docs, Lorna Warwick, and our Mount Sinai NYC team!”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 29, 2024, 20:13
Nov 29, 2024, 20:00
Nov 29, 2024, 19:25
Nov 29, 2024, 19:20
Nov 29, 2024, 18:56